| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |